Tai-Sheng Li,Ling Lin
Tai-Sheng Li
Keep Eyes on COVID-19: Ophthalmic Symptoms and Potential Transmission of SARS-CoV-2 through the Oculus [0.03%]
警惕新型冠状病毒经结膜感染的可能性及相关眼部表现
Hong Li Ran,Xiang Tian Zhou,William J Liu et al.
Hong Li Ran et al.
In December 2019, a new coronavirus disease 2019 (COVID-19) emerged and rapidly spread globally, posing a worldwide health emergency. The pathogen causing this pandemic was identified as severe acute respiratory syndrome coronavirus-2 (SARS...
The Progress and Challenges of Convalescent Plasma Therapy for Coronavirus Disease 2019 [0.03%]
新冠肺炎恢复期血浆治疗的进展与挑战
Ming Shi,Chao Zhang,Fu-Sheng Wang
Ming Shi
Middle East respiratory syndrome (MERS), severe acute respiratory syndrome (SARS), and SARS-CoV-2 infection (causing coronavirus disease 2019 [COVID-19]) are serious diseases. To date, no effective post-exposure prophylaxis, prevention, or ...
Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 8th Edition): Interpretation of Updated Key Points [0.03%]
《新冠肺炎诊疗方案(试行第八版)重点更新内容解读》
Gui-Qiang Wang,Lei Zhao,Xia Wang et al.
Gui-Qiang Wang et al.
Risk Factors for Severity and Mortality in Adult Patients Confirmed with COVID-19 in Sierra Leone: A Retrospective Study [0.03%]
塞拉利昂新冠肺炎成人患者病情严重程度及死亡率危险因素的回顾性研究
Bo Tu,Sulaiman Lakoh,Biao Xu et al.
Bo Tu et al.
Background: The coronavirus disease 2019 (COVID-19) is a highly infectious respiratory disease. There is no recommended antiviral treatment approved for COVID-19 in Sierra Leone, and supportive care and protection of vita...
Effectiveness and Controversy of Convalescent Plasma Therapy for Coronavirus Disease 2019 Patients [0.03%]
新冠肺炎康复血浆治疗的有效性和争议性
Zhanjun Shu,Peipei Wu,Qianqian Qian et al.
Zhanjun Shu et al.
Since the coronavirus disease 2019 (COVID-19) began to spread, it remains pandemic worldwide. The European Medicines Agency's human medicines committee and Food and Drug Administration have only granted a conditional marketing authorization...
Reinfection and Breakthrough Infection of SARS-CoV-2: An Emerging Challenge That Is Threatening Our World [0.03%]
新冠病毒再感染和突破性感染：正在威胁我们的世界的一项新兴挑战
Lin Gao,Xiuying Mu,Yan-Mei Jiao et al.
Lin Gao et al.
The pandemic of coronavirus disease 2019 has threatened humans for more than one and a half years. In particular, viral mutation like delta strain has led to third- or fourth-wave transmission among the countries in Asia, Europe, and North ...
Advances in Research on COVID-19 Vaccination for People Living with HIV [0.03%]
关于HIV感染者接种新冠肺炎疫苗研究进展的述评
Junyan Jin,Xiuwen Wang,Raphael Carapito et al.
Junyan Jin et al.
Examination of Homologies between COVID-19 Vaccines and Common Allergens: The Potential for T Cell-mediated Responses for Allergic Rhinitis and Asthma [0.03%]
对COVID-19疫苗与常见过敏原同源性的检测：T细胞介导的反应引发过敏性鼻炎和哮喘的潜在可能性
Micah Hartwell,Benjamin H Greiner,Savannah Nicks
Micah Hartwell
As the SARS-CoV-2 virus shares relatively large protein sequences homologous to grass pollens, dust mites, and molds, our objective was to assess the potential overlap between the COVID-19 mRNA vaccines from Pfizer-BioNtech and Moderna and ...
Wen-Yi Dong,Ming-Ju Zhou,Lei Huang et al.
Wen-Yi Dong et al.
Severe acute respiratory syndrome coronavirus-2 infection is usually self-limited, with a short duration for viral shedding within several weeks. However, prolonged viral shedding has been observed in severe or immune-compromised coronaviru...